Veru Inc (VERU)

$5.48 0.00 (0.00%)

16:00 EST VERU Stock Quote Delayed 30 Minutes

Why Is VERU Stock Down 50% Today?

By David Moadel, InvestorPlace Contributor Nov 10, 2022

The regulatory hammer is hitting VERU stock investors hard today as the FDA denies a crucial authorization for Veru's Covid-19 drug.

VERU Stock Soars 40% Despite Uncertainty Surrounding Covid-19 Drug

7 Long-Term Stocks to Buy to Tap Into a Hidden Bull Market

7 Momentum Stocks to Buy Now for Extraordinary Gains

Volume:

Previous Close -

Market Cap 439.20M

PE Ratio -9.29

EPS -0.59

Volume (Avg. Vol.) 31,595

Day's Range -

52-Week Range $4.34 - $24.55

Dividend & Yield N/A (N/A)

VERU Stock Predictions, Articles, and Veru Inc News

From InvestorPlace
From the Web

Why Is VERU Stock Up 36% Today?

By William White, InvestorPlace Writer Aug 11, 2022

Veru (VERU) stock is heading higher on Thursday as investors celebrate positive news in its earnings report for fiscal Q3 2022.

7 Small-Cap Growth Stocks With 1,000% Upside Potential

By Tezcan Gecgil, InvestorPlace Contributor Jul 31, 2022

Here're 7 small-cap growth stocks with 1,000% upside potential. ACLS, AXSM, GBT, GPRO, HCAT, SKLZ, and VERU can make great investments.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 7, 2022

Good morning, trader! We're taking a look at the biggest pre-market stock movers for Thursday that investors need to know about!

VERU Stock Pops on Clinical Trial Update

By William White, InvestorPlace Writer Jul 6, 2022

Veru (VERU) stock is on the move Wednesday after the company published results from its Phase 3 clinical trial of sabizabulin.

VERU Stock Alert: 6 Things to Know as Veru Appoints a New Executive

By William White, InvestorPlace Writer May 18, 2022

Veru (VERU) stock is on the move Wednesday following news of the biopharmaceutical company adding Joel Batten to its list of executives.

Catch Fast-Moving Veru Stock as Covid-19 Drug Results Show Promise

By Louis Navellier and the InvestorPlace Research Staff May 17, 2022

VERU stock's rapid upward trajectory could continue as Veru releases its fiscal results and marks a significant clinical milestone.

Short Squeeze Stocks: VTNR, VERU and 3 Others Experts Think Are Ready to Pop

By Shrey Dua, InvestorPlace Assistant News Writer May 16, 2022

Short squeeze stocks are once again in focus this week as the bears continue to run wild in the stock market.

VERU Stock Pops on a Covid-19 Treatment Milestone

By William White, InvestorPlace Writer May 11, 2022

Veru (VERU) stock is rising higher on Wednesday following a recent ruling from the FDA concerning the company's Covid-19 treatment.

Veru Stock Could Face Difficulties If the Culper Research Report Is True

By Mark R. Hake, CFA May 9, 2022

VERU stock could face major problems with investors if some of the glaring issues raised by the Culper Research report are true.

Short Squeeze Stocks: HCDI, ZYME and 3 Others Experts Think Are Ready to Pop

By Shrey Dua, InvestorPlace Assistant News Writer May 2, 2022

Short squeeze stocks are once again in focus this week as Fintel released its weekly Short Squeeze Leaderboard report. Let's take a look.

Why Is Veru (VERU) Stock On the Move Again Today?

By William White, InvestorPlace Writer Apr 14, 2022

Veru (VERU) stock is continuing to move today with a few factors affecting the recent change in the biopharmaceutical company's shares.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Apr 12, 2022

Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!

Why Is Veru (VERU) Stock Up 200% Today?

By William White, InvestorPlace Writer Apr 11, 2022

Veru (VERU) stock is taking off on Monday as investors react to recent clinical trial news about the company's Covid-19 treatment.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Apr 11, 2022

Rise and shine, investor! It's time to start off another week of trading with the biggest pre-market stock movers for Monday!

5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet

By Samuel O'Brient, InvestorPlace Financial News Writer Feb 4, 2022

Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit.

7 Top-Rated Pharmaceutical Stocks To Invest in for October

By Louis Navellier and the InvestorPlace Research Staff Oct 4, 2021

It's a great time to look beyond the big name pharmaceutical stocks and look for great niche players with big futures.

VERU Stock News: 9 Things for Investors to Know About Veru Breast Cancer Trial Results

By William White, InvestorPlace Writer Dec 14, 2020

Veru (VERU) stock is doing well on Monday after announcing positive news from a Phase 2 clinical trial of its breast cancer drug.

7 Sin Stocks Whose Profits Are Too Irresistible to Pass Up

By Will Ashworth, InvestorPlace Contributor Aug 5, 2020

If you’re able to overlook the shortcomings of these seven sin stocks, your long-term gains will be enough to soothe your conscience.

7 ‘A’-Rated Stocks Under $5 to Buy Now

By Louis Navellier, Editor, Growth Investor Feb 7, 2020

These small-cap stocks to buy are all under $5, but they come from industries and sectors with massive potential.

Is It Too Late to Buy Veru Stock?

From The Motley Fool Nov 23, 2022

The negative impact of its COVID-19 program faltering will soon be in the past.

Why Shares of Veru Fell 10.33% on Monday

From The Motley Fool Nov 21, 2022

Investors are concerned that approval for a COVID-19 therapy will be delayed or denied.

Why Veru Stock Was Losing One-Third of Its Value This Week

From The Motley Fool Nov 11, 2022

The future of a top pipeline drug now looks much dimmer.

Why Veru Stock Is Cratering Today

From The Motley Fool Nov 10, 2022

A negative vote on one of its drugs is weighing on the biotech's stock price.

Veru Tanks After FDA Snub For COVID-19 Therapy

From TipRanks Nov 10, 2022

Shares of Veru (NASDAQ: VERU) tanked more than 60% in pre-market trading on Thursday after the advisory committee meeting at the U.S. FDA voted against granting the...

VERU stock crashes after AdCom snub for COVID-19 therapy (NASDAQ:VERU)

From Seeking Alpha Nov 10, 2022

Veru Inc. (VERU), a biopharma targeting cancer, shed ~65% of its value on Thursday pre-market after a group of independent experts at the FDA voted against granting the emergency...

Veru Inc (VERU)

Why Is VERU Stock Down 50% Today?

VERU Stock Soars 40% Despite Uncertainty Surrounding Covid-19 Drug

7 Long-Term Stocks to Buy to Tap Into a Hidden Bull Market

7 Momentum Stocks to Buy Now for Extraordinary Gains

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Veru Inc (VERU)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

VERU Stock Predictions, Articles, and Veru Inc News

Subscriber Sign in